학술논문

Minimal residual disease (MRD) by flow cytommetry immediately before autologous stem cell transplantation (ASCT) in acute myeloid leukemia (AML): A critical factor in outcome?
Document Type
Journal
Source
BLOOD; NOV 15 1999, 94 10, p580A-p580A, 1p. Supplement: 1
Subject
Language
English
ISSN
00064971